Clearity Foundation's range of services, including lab test coordination, tumor blueprint interpretation, and clinical trial identification, is provided free of charge. The organization prioritizes therapy options for recurrent and refractory ovarian cancer, educates patients and physicians about the value of molecular profiling in diagnosis and treatment, and expedites the clinical development of novel targeted agents for ovarian cancer by creating a database that correlates tumor molecular profiles with treatment outcomes.
Clearity operates in the Biotechnology and Health Care sectors, aiming to create a significant impact in the field of ovarian cancer treatment. As of the latest available data, details regarding their headquarters, last investment, and investors are not provided.